5 results  1 of 1 

1 Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
Byung Wan Lee, KyungWan Min, Eun-Gyoung Hong, Bon Jeong Ku, Jun Goo Kang, Suk Chon, Won-Young Lee, Mi Kyoung Park, Jae Hyeon Kim, Sang Yong Kim, Keeho Song, Soon Jib Yoo
Endocrinol Metab.2023;38(3):328-337.   Published online 2023 June 28     DOI: http://dx.doi.org/10.3803/EnM.2023.1688
      
2 Effect of gemigliptin on cardiac ischemia/reperfusion and spontaneous hypertensive rat models
Dae-Hwan Nam, Jinsook Park, Sun-Hyun Park, Ki-Suk Kim, Eun Bok Baek
Korean J Physiol Pharmacol.2019;23(5):329-334.   Published online 2019 August 26     DOI: http://dx.doi.org/10.4196/kjpp.2019.23.5.329
      
3 Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
Jung Beom Seo, Yeon-Kyung Choi, Hye-In Woo, Yun-A Jung, Sungwoo Lee, Seunghyeong Lee, Mihyang Park, In-Kyu Lee, Gwon-Soo Jung, Keun-Gyu Park
Diabetes Metab J.2019;43(6):830-839.   Published online 2019 March 5     DOI: http://dx.doi.org/10.4093/dmj.2018.0181
      
4 Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
Hae Jin Kim, Eun Bok Baek, Sung Joon Kim
Korean J Physiol Pharmacol.2018;22(6):713-719.   Published online 2018 October 25     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.6.713
      
5 Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects
Yong-Soon Cho, Shi Hyang Lee, Hyeong-Seok Lim, Kyun-Seop Bae
J Korean Med Sci.2018;33(41):e258.  Published online 2018 September 5     DOI: http://dx.doi.org/10.3346/jkms.2018.33.e258
      

 1 of 1